COMMUNIQUÉS West-GlobeNewswire

Johnson & Johnson announces expected settlement of Actelion tender offer on June 16, 2017

09/06/2017 - 17:38

Announces receipt of all regulatory approvals required to complete acquisition of Actelion ALLSCHWIL/BASEL, SWITZERLAND - 09 June 2017 - Johnson & Johnson (NYSE:JNJ) today announced that, with today's receipt of [...]

Targovax ASA: Notice of Extraordinary General Meeting

09/06/2017 - 15:41

An Extraordinary General Meeting of Targovax ASA will be held at the Company's offices at Lysaker, on 30 June 2017 at 09:00 CET. Please find the notice including agenda for the Extraordinary General Meeting and [...]

Sixth Annual HOOPP LEAP Awards Honours Property Managers and Tenants for Outstanding Performance, Collaboration and Innovation

09/06/2017 - 14:00

TORONTO, June 09, 2017 (GLOBE NEWSWIRE) -- The Healthcare of Ontario Pension Plan (HOOPP) once again reinforced its role as a global leader in real estate sustainability practices by honouring property managers and [...]

La sixième cérémonie annuelle de remise des prix HOOPP LEAP honore les gestionnaires immobiliers et les locataires pour un rendement, une collaboration et une innovation exceptionnels

09/06/2017 - 14:00

TORONTO, le 9 juin 2017 (GLOBE NEWSWIRE) - Le Healthcare of Ontario Pension Plan (HOOPP) a de nouveau renforcé son rôle de leader mondial dans les pratiques de durabilité immobilière en honorant les gestionnaires [...]

Targovax ASA - Information on the subsequent offering - Key date information

09/06/2017 - 07:52

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]

Mithra Pharmaceuticals: MITHRA RECEIVES ORPHAN DRUG DESIGNATION FROM EMA FOR E4 IN NEONATAL ENCEPHALOPATHY

09/06/2017 - 07:30

PRESS RELEASE Mithra RECEIVES ORPHAN DRUG DESIGNATION FROM EMA FOR E4 IN NEONATAL ENCEPHALOPATHY Orphan Drug Designation received from European Medicines Agency for Estetrol (E4) in the treatment of life-threatening [...]

KISSEI TO MARKET AVACOPAN IN JAPAN FOR VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA

09/06/2017 - 06:58

PRESS RELEASE This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]

NICOX : Issuing and admission to trading on the Euronext regulated market in Paris of 597,897 new shares awarded to former Aciex shareholders following the US FDA's approval of ZERVIATE

09/06/2017 - 01:05

Press release This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]

Communiqué rectificatif: Emission et admission aux négociations sur le marché réglementé d'Euronext à Paris de 597.897 actions nouvelles attribuées aux anciens actionnaires d'Aciex suite à l'approb...

09/06/2017 - 00:05

Communiqué de presse This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for [...]

TARGOVAX ASA - SUCCESSFULLY COMPLETED PRIVATE PLACEMENT

08/06/2017 - 22:30

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]

Novartis presents data demonstrating efficacy of AMG 334 (erenumab) in migraine prevention at the American Headache Society Annual Meeting

08/06/2017 - 22:30

Data from the comprehensive clinical program show AMG 334 (erenumab) is safe and effective at preventing migraine in patients with 4 or more migraine days per month AMG 334 (erenumab) significantly reduced monthly [...]

Nicox: Emission et admission aux négociations sur le marché réglementé d'Euronext à Paris de 597 897 actions nouvelles attribuées aux anciens actionnaires d'Aciex suite à l'approbation du ZERVIATE

08/06/2017 - 20:00

Communiqué de presse Nicox annonce l'émission et l'admission aux négociations sur le marché réglementé d'Euronext à Paris de 597.897 actions nouvelles attribuées aux anciens actionnaires d'Aciex suite à l'approbation [...]

Nicox: Issuing and admission to trading on the Euronext regulated market in Paris of 597,897 new shares awarded to existing Aciex shareholders following the US FDA's approval of ZERVIATE

08/06/2017 - 20:00

Press Release Nicox announces the issuing and admission to trading on the Euronext regulated market in Paris of 597,897 new shares awarded to existing Aciex shareholders following the US FDA's approval of the new drug [...]

Solon Eiendom ASA - Primary insider notification

08/06/2017 - 18:08

SOLON EIENDOM ASA STOCK EXCHANGE ANNOUNCEMENT Solon Eiendom ASA - Primary insider notification (Oslo, Norway, 8 June 2017) Solon Eiendom ASA Chairman of the Board Simen Thorsen (through his wholly owned company Hortulan [...]

CROSSJECT : point d'activité

08/06/2017 - 18:00

Point d'activité Confirmation du calendrier des dépôts d'AMM Dijon, le 8 juin 2017 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe un portefeuille de médicaments combinés innovants [...]

CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social

08/06/2017 - 18:00

Information relative au nombre total de droits de vote et d'actions composant le capital social 8 juin 2017 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe un portefeuille de [...]

Eckert & Ziegler BEBIG: Paola Eckert-Palvarini élue membre du Conseil d'administration.

08/06/2017 - 15:30

Communiqué de presse INFORMATIONS RÉGLEMENTÉES Seneffe, 8 juin 2017. Lors de l'Assemblée générale annuelle qui s'est tenue aujourd'hui à Seneffe (Belgique), les actionnaires de Eckert & Ziegler BEBIG SA ont nommé [...]

The IPO of Silmäasema Oyj has been oversubscribed and the final subscription price is EUR 6.90 per share

08/06/2017 - 14:00

Stock Exchange Release 8 June 2017, at 3 p.m. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG, SOUTH AFRICA, SINGAPORE OR JAPAN OR ANY [...]

HomeVi announces that PAI Partners has entered into exclusive negotiations with ICG and Yves Journel for the sale of a majority stake in the DomusVi group

08/06/2017 - 09:30

Suresnes, June 8th, 2017 - 9:30 am HomeVi S.A.S. ("HomeVi") today announced that its controlling shareholder, PAI Partners, has entered into exclusive negotiations with Intermediate Capital Group ("ICG") and Sagesse [...]